Abstract

Witamina D, poza istotną rolą w utrzymaniu homeostazy wapnia i metabolizmie kostnym, odgrywa ważną rolę w funkcjonowaniu układu odpornościowego. Niedobór witaminy D wiąże się z wieloma niekorzystnymi dla zdrowia skutkami, włączając w to m.in. osłabienie odporności, czego skutkiem jest zwiększona podatność na zakażenia wirusowe, bakteryjne oraz grzybicze. W artykule opisano podstawy metabolizmu witaminy D oraz jej rolę fizjologiczną, ze szczególnym uwzględnieniem wpływu na komórki układu odpornościowego. Ze względu na jej istotną rolę w regulacji odpowiedzi zapalnej oraz wytwarzaniu cytokin zwraca się uwagę na jej rolę w rozwoju chorób o podłożu autoimmunologicznym, takich jak cukrzyca typu 1, toczeń rumieniowaty, reumatoidalne zapalenie stawów, stwardnienie rozsiane, nieswoiste zapalenia jelit, łuszczyca, bielactwo, czy twardzina, w których witamina D ma potencjalne szerokie zastosowanie zarówno w prewencji, jak i wspomaganiu działań terapeutycznych.

References

• 1. Abou-Raya A., Abou-Raya S., Helmii M.: The effect of vitamin Dsupplementation on inflammatory and hemostatic markers and diseaseactivity in patients with systemic lupus erythematosus: a randomizedplacebo-controlled trial. J. Rheumatol., 2013; 40: 265-272
  Google Scholar
• 2. Abraham D.J., Krieg T., Distler J., Distler O.: Overview of pathogenesisof systemic sclerosis. Rheumatology, 2009; 48, Suppl. 3: iii3-iii7
  Google Scholar
• 3. Adler J., Rangwalla S.C., Dwamena B.A., Higgins P.D.: The prognosticpower of the NOD2 genotype for complicated Crohn’s disease:a meta-analysis. Am. J. Gastroenterol., 2011; 106: 699-712
  Google Scholar
• 4. Alkhateeb A., Fain P.R., Thody A., Bennett D.C., Spritz R.A.: Epidemiologyof vitiligo and associated autoimmune diseases in Caucasianprobands and their families. Pigment Cell Res., 2003; 16: 208-214
  Google Scholar
• 5. Alroy I., Towers T.L., Freedman L.P.: Transcriptional repressionof the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell.Biol., 1995; 15: 5789-5799
  Google Scholar
• 6. Al-Temaimi R.A., Al-Enezi A., Al-Serri A., Al-Roughani R., AlMullaF.: The association of vitamin D receptor polymorphisms withmultiple sclerosis in a case-control study from Kuwait. PLoS One,2015; 10: e0142265
  Google Scholar
• 7. Amital H., Szekanecz Z., Szücs G., Dankó K., Nagy E., Csépány T.,Kiss E., Rovensky J., Tuchynova A., Kozakova D., Doria A., CorocherN., Agmon-Levin N., Barak V., Orbach H., Zandman-Goddard G., ShoenfeldY.: Serum concentrations of 25-OH vitamin D in patients withsystemic lupus erythematosus (SLE) are inversely related to diseaseactivity: is it time to routinely supplement patients with SLE withvitamin D? Ann. Rheum. Dis., 2010; 69: 1155-1157
  Google Scholar
• 8. Aranow C., Kamen D.L., Dall’Era M., Massarotti E.M., MackayM.C., Koumpouras F., Coca A., Chatham W.W., Clowse M.E., CriscioneSchreiberL.G., Callahan S., Goldmuntz E.A., Keyes-Elstein L., OswaldM., Gregersen P.K., Diamond B.: Randomized, double-blind, placebocontrolledtrial of the effect of vitamin D3 on the interferon signaturein patients with systemic lupus erythematosus. Arthritis Rheumatol.,2015; 67: 1848-1857
  Google Scholar
• 9. Ardesia M., Ferlazzo G., Fries W.: Vitamin D and inflammatorybowel disease. Biomed. Res. Int., 2015; 2015: 470805
  Google Scholar
• 10. Arnson Y., Amital H., Agmon-Levin N., Alon D., Sánchez-Casta-ñón M., López-Hoyos M., Matucci-Cerinic M., Szücs G., Shapira Y.,Szekanecz Z., Shoenfeld Y.: Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemicsclerosis: a retrospective cohort study and review of the literature.Autoimmun. Rev., 2011; 10: 490-494
  Google Scholar
• 11. Ascherio A., Munger K.L., Lünemann J.D.: The initiation andprevention of multiple sclerosis. Nat. Rev. Neurol., 2012; 8: 602-612
  Google Scholar
• 12. Atteritano M., Sorbara S., Bagnato G., Miceli G., Sangari D., MorganteS., Visalli E., Bagnato G.: Bone mineral density, bone turnovermarkers and fractures in patients with systemic sclerosis: a casecontrol study. PLoS One, 2013; 8: e66991
  Google Scholar
• 13. Baeke F., Korf H., Overbergh L., van Etten E., Verstuyf A., GysemansC., Mathieu C.: Human T lymphocytes are direct targets of1,25-dihydroxyvitamin D3 in the immune system. J. Steroid Biochem.Mol. Biol., 2010; 121: 221-227
  Google Scholar
• 14. Baeke F., Korf H., Overbergh L., Verstuyf A., Thorrez L., Van LommelL., Waer M., Schuit F., Gysemans C., Mathieu C.: The vitamin Danalog, TX527, promotes a human CD4+CD25highCD127low regulatoryT cell profile and induces a migratory signature specific for homingto sites of inflammation. J. Immunol.; 2011; 186: 132-142
  Google Scholar
• 15. Baraut J., Michel L., Verrecchia F., Farge D.: Relationship betweencytokine profiles and clinical outcomes in patients with systemicsclerosis. Autoimmun. Rev., 2010; 10: 65-73
  Google Scholar
• 16. Becher B., Pantelyushin S.: Hiding under the skin: Interleukin-17-producingγδ T cells go under the skin? Nat. Med., 2012; 18:1748-1750
  Google Scholar
• 17. Berger A.: Th1 and Th2 responses: what are they? Br. Med. J.,2000; 321: 424
  Google Scholar
• 18. Bikle D.D.: Vitamin D metabolism and function in the skin. Mol.Cell. Endocrinol., 2011; 347: 80-89
  Google Scholar
• 19. Birlea S.A., Costin G.E., Norris D.A.: Cellular and molecular mechanismsinvolved in the action of vitamin D analogs targeting vitiligodepigmentation. Curr. Drug Targets, 2008; 9: 345-359
  Google Scholar
• 20. Bogaczewicz J., Sysa-Jędrzejowska A., Arkuszewska C., Hawro T.,Ząbek T., Karczmarewicz E., Lorenc R.S., Płudowski P., Woźniacka A.:Potrzeba suplementacji witaminy D u chorych na toczeń rumieniowatyukładowy. Reumatologia, 2008; 46: 223-229
  Google Scholar
• 21. Borissova A.M., Tankova T., Kirilov G., Dakovska L., Kovacheva R.:The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivityin type 2 diabetic patients. Int. J. Clin. Pract., 2003; 57: 258-261
  Google Scholar
• 22. Borzutzky A., Fried A., Chou J., Bonilla F.A., Kim S., Dedeoglu F.:NOD2-associated diseases: Bridging innate immunity and autoinflammation.Clin. Immunol., 2010; 134: 251-261
  Google Scholar
• 23. Bowcock A.M., Shannon W., Du F., Duncan J., Cao K., AftergutK., Catier J., Fernandez-Vina M.A., Menter A.: Insights into psoriasisand other inflammatory diseases from large-scale gene expressionstudies. Hum. Mol. Genet., 2001; 10: 1793-1805
  Google Scholar
• 24. Boyan B.D., Wong K.L., Fang M., Schwartz Z.: 1α,25(OH)2D3 is anautocrine regulator of extracellular matrix turnover and growth factorrelease via ERp60 activated matrix vesicle metalloproteinases. J.Steroid Biochem. Mol. Biol., 2007; 103: 467-472
  Google Scholar
• 25. Brown J., Bianco J.I., McGrath J.J., Eyles D.W.: 1,25-DihydroxyvitaminD3 induces nerve growth factor, promotes neurite outgrowthand inhibits mitosis in embryonic rat hippocampal neurons. Neurosci.Lett., 2003; 343: 139-143
  Google Scholar
• 26. Bryl E., Witkowski J.M.: Układ odpornościowy a reumatoidalnezapalenie stawów. Forum Med. Rodz., 2008; 2: 196-207
  Google Scholar
• 27. Buczkowski K., Chlabicz S., Dytfeld J., Horst-Sikorska W., JaroszyńskiA., Kardas P., Marcinkowska M., Siebert J., Tałałaj M.: Wytycznedla lekarzy rodzinnych dotyczące suplementacji witaminyD. Forum Med. Rodz., 2013; 7: 55-58
  Google Scholar
• 28. Chen J., Olivares-Navarrete R., Wang Y., Herman T.R., BoyanB.D., Schwartz Z.: Protein-disulfide isomerase-associated 3 (Pdia3)mediates the membrane response to 1,25-dihydroxyvitamin D3 inosteoblasts. J. Biol. Chem., 2010; 285: 37041-37050
  Google Scholar
• 29. Chen S., Sims G.P., Chen X.X., Gu Y.Y., Chen S., Lipsky P.E.: Modulatoryeffects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.J. Immunol., 2007; 179: 1634-1647
  Google Scholar
• 30. Christakos S., Ajibade D.V., Dhawan P., Fechner A.J., Mady L.J.:Vitamin D: metabolism. Endocrinol. Metab. Clin. North Am., 2010;39: 243-253
  Google Scholar
• 31. Cippitelli M., Santoni A.: Vitamin D3: a transcriptional modulatorof the interferon-g gene. Eur. J. Immunol., 1998; 28: 3017-3030
  Google Scholar
• 32. Cipriani P., Di Benedetto P., Ruscitti P., Campese A.F., LiakouliV., Carubbi F., Pantano I., Berardicurt O., Screpanti I., Giacomelli R.:Impaired endothelium-mesenchymal stem cells cross-talk in systemicsclerosis: a link between vascular and fibrotic features. ArthritisRes. Ther., 2014; 16: 442
  Google Scholar
• 33. Cooles F.A., Isaacs J.D., Anderson A.E.: Treg cells in rheumatoidarthritis: an update. Curr. Rheumatol. Rep., 2013; 15: 352
  Google Scholar
• 34. Cooper J.D., Smyth D.J., Walker N.M., Stevens H., Burren O.S., WallaceC., Greissl C., Ramos-Lopez E., Hyppönen E., Dunger D.B., SpectorT.D., Ouwehand W.H., Wang T.J., Badenhoop K., Todd J.A.: Inheritedvariation in vitamin D genes is associated with predisposition to autoimmunedisease type 1 diabetes. Diabetes, 2011; 60: 1624-1631
  Google Scholar
• 35. Correale J., Ysrraelit M.C., Gaitán M.I.: Immunomodulatory effectsof vitamin D in multiple sclerosis. Brain, 2009; 132: 1146-1160
  Google Scholar
• 36. Craig S.M., Yu F., Curtis J.R., Alarcón G.S., Conn D.L., Jonas B.,Callahan L.F., Smith E.A., Moreland L.W., Bridges S.L.Jr., Mikuls T.R.:Vitamin D status and its associations with disease activity and severityin African Americans with recent-onset rheumatoid arthritis. J.Rheumatol., 2010; 37: 275-281
  Google Scholar
• 37. D’Ambrosio D., Cippitelli M., Cocciolo M.G., Mazzeo D., Di LuciaP, Lang R., Sinigaglia F., Panina-Bordignon P.: Inhibition of IL-12production by 1,25-dihydroxyvitamin D3. Involvement of NF-κBdownregulation in transcriptional repression of the p40 gene. J.Clin. Invest., 1998; 101: 252-262
  Google Scholar
• 38. DeLuca H.F.: Overview of general physiologic features and functionsof vitamin D. Am. J. Clin. Nutr., 2004; 80 (Suppl. 1): 1689S-1696S
  Google Scholar
• 39. Dwivedi M., Laddha N.C., Arora P., Marfatia Y.S., Begum R.: Decreasedregulatory T-cells and CD4+/CD8+ ratio correlate with diseaseonset and progression in patients with generalized vitiligo. PigmentCell Melanoma Res., 2013; 26: 586-591
  Google Scholar
• 40. El-Komy M.H., Samir N., Shaker O.G.: Estimation of vitamin Dlevels in patients with pemphigus vulgaris. J. Eur. Acad. Dermatol.Venereol., 2014; 28: 859-863
  Google Scholar
• 41. El-Moaty Zaher H.A., El-Komy M.H., Hegazy R.A., El KhashabM.H., Ahmed H.H.: Assessment of interleukin-17 and vitamin D serumlevels in psoriatic patients. J. Am. Acad. Dermatol., 2013; 69:840-842
  Google Scholar
• 42. Eyles D.W., Smith S., Kinobe R., Hewison M., McGraht J.J.: Distributionof the vitamin D receptor and 1α-hydroxylase in humanbrain. J. Chem. Neuroanat., 2005; 29: 21-30
  Google Scholar
• 43. Farraye F.A., Nimitphong H., Stucchi A., Dendrinos K., BoulangerA.B., Vijjeswarapu A., Tanennbaum A., Biancuzzo R., Chen T.C., HolickM.F.: Use of a novel vitamin D bioavailability test demonstrates thatvitamin D absorption is decreased in patients with quiescent Crohn’sdisease. Inflamm. Bowel Dis., 2011; 17: 2116-2121
  Google Scholar
• 44. Feng X., Lv C., Wang F., Gan K., Zhang M., Tan W.: Modulatoryeffect of 1,25-dihydroxyvitamin D3 on IL1 β -induced RANKL, OPG,TNF α, and IL-6 expression in human rheumatoid synoviocyte MH7A.Clin. Dev. Immunol., 2013; 2013: 160123
  Google Scholar
• 45. Garg M., Lubel J.S., Sparrow M.P., Holt S.G., Gibson P.R.: Reviewarticle: vitamin D and inflammatory bowel disease – establishedconcepts and future directions. Aliment. Pharmacol. Ther., 2012;36: 324-344
  Google Scholar
• 46. Gisondi P., Rossini M., Di Cesare A., Idolazzi L., Farina S., BeltramiG., Peris K., Girolomoni G.: Vitamin D status in patients with chronicplaque psoriasis. Br. J. Dermatol., 2012; 166: 505-510
  Google Scholar
• 47. Grazio S., Naglić Đ.B., Anić B., Grubišić F., Bobek D., Bakula M.,Kavanagh H.S., Kuna A.T., Cvijetić S.: Vitamin D serum level, diseaseactivity and functional ability in different rheumatic patients. Am.J. Med. Sci., 2015; 349: 46-49
  Google Scholar
• 48. Gregori S., Giarratana N., Smiroldo S., Uskokovic M., Adorini L.:A 1α,25-dihydroxyvitamin D3 analog enhances regulatory T-cellsand arrests autoimmune diabetes in NOD mice. Diabetes, 2002; 51:1367-1374
  Google Scholar
• 49. Griffin M.D., Lutz W., Phan V.A., Bachman L.A., McKean D.J., KumarR.: Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 andits analogs: a vitamin D receptor-dependent pathway that promotesa persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad.Sci. USA, 2001; 98: 6800-6805
  Google Scholar
• 50. Gullick N.J., Evans H.G., Church L.D., Jayaraj D.M., Filer A.,Kirkham B.W., Taams L.S.: Linking power Doppler ultrasound tothe presence of Th17 cells in the rheumatoid arthritis joint. PLoSOne, 2010; 5: e12516
  Google Scholar
• 51. Hansen K.E., Bartels C.M., Gangnon R.E., Jones A.N., GogineniJ.: An evaluation of high-dose vitamin D for rheumatoid arthritis. J.Clin. Rheumatol., 2014; 20: 112-114
  Google Scholar
• 52. Harandi A.A., Harandi A.A., Pakdaman H., Sahraian M.: VitaminD and multiple sclerosis. Iran. J. Neurol., 2014; 13: 1-6
  Google Scholar
• 53. Hewison M.: Vitamin D and the intracrinology of innate immunity.Mol. Cell. Endocrinol., 2010; 321: 103-111
  Google Scholar
• 54. Hossani-Madani A.R., Halder R.M.: Topical treatment and combinationapproaches for vitiligo: new insights, new developments.G. Ital. Dermatol. Venereol., 2010; 145: 57-78
  Google Scholar
• 55. Hossein-Nezhad A., Spira A., Holick M.F.: Influence of vitaminD status and vitamin D3 supplementation on genome wide expressionof white blood cells: a randomized double-blind clinical trial.PLoS One, 2013; 8: e58725
  Google Scholar
• 56. Hyppönen E., Läärä E., Reunanen A., Järvelin M.R., VirtanenS.M.: Intake of vitamin D and risk of type 1 diabetes: a birth-cohortstudy. Lancet, 2001; 358: 1500-1503
  Google Scholar
• 57. Jasik A., Tałałaj M.: Witamina D a reumatoidalne zapalenie stawów.Postępy Nauk Med., 2012; 3: 237-240
  Google Scholar
• 58. Jasiuk B., Reich A.: Znaczenie apoptozy w patogenezie toczniarumieniowatego układowego. Dermatol. Klin., 2005; 7: 97-100
  Google Scholar
• 59. Kaczmarczyk M., Niedźwiecka P., Deptuła W.: Charakterystykakomórek dendrytycznych. Adv. Clin. Exp. Med., 2006; 15: 871-879
  Google Scholar
• 60. Kamen D.L., Cooper G.S., Bouali H., Shaftman S.R., Hollis B.W.,Gilkeson G.S.: Vitamin D deficiency in systemic lupus erythematosus.Autoimmun. Rev., 2006; 5: 114-117
  Google Scholar
• 61. Khoo A.L., Chai L.Y., Koenen H.J., Oosting M., Steinmeyer A.,Zuegel U., Joosten I., Netea M.G., van der Ven A.J.: Vitamin D3down’regulates proinflammatory cytokine response to Mycobacteriumtuberculosis through pattern recognition receptors while inducingprotective cathelicidin production. Cytokine, 2011; 55: 294-300
  Google Scholar
• 62. Klein S., Kretz C.C., Ruland V., Stumpf C., Haust M., Hartschuh W.,Hartmann M., Enk A., Suri-Payer E., Oberle N., Krammer P.H., KuhnA.: Reduction of regulatory T cells in skin lesions but not in peripheralblood of patients with systemic scleroderma. Ann. Rheum. Dis.,2011; 70: 1475-1481
  Google Scholar
• 63. Kmieć P., Sworczak K.: Vitamin D deficiency in early autumnamong predominantly non-elderly, urban adults in Northern Poland(54°N). Postępy Hig. Med. Dośw., 2015; 69: 918-924
  Google Scholar
• 64. Kmieć P., Żmijewski M., Lizakowska-Kmieć M., Sworczak K.:Widespread vitamin D deficiency among adults from northern Poland(54°N) after months of low and high natural UVB radiation.Endokrynol. Pol., 2015; 66: 30-38
  Google Scholar
• 65. Kmieć P., Żmijewski M., Waszak P., Sworczak K., LizakowskaKmiećM.: Vitamin D deficiency during winter months among anadult, predominantly urban, population in Northern Poland. Endokrynol.Pol., 2014; 65: 105-113
  Google Scholar
• 66. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., OchoaM.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., BalsR., Steinmeyer A., Zügel U. i wsp.: Toll-like receptor triggering ofa vitamin D-mediated human antimicrobial response. Science, 2006;311: 1770-1773
  Google Scholar
• 67. Losel R.M., Falkenstein E., Feuring M., Schultz A., Tillmann H.C.,Rossol-Haseroth K., Wehling M.: Nongenomic steroid action: controversies,questions, and answers. Physiol. Rev., 2003; 83: 965-1016
  Google Scholar
• 68. Marston B., Palanichamy A., Anolik J.H.: B cells in the pathogenesisand treatment of rheumatoid arthritis. Curr. Opin. Rheumatol.,2010; 22: 307-315
  Google Scholar
• 69. Marzano A.V., Trevisan V., Cairoli E., Eller-Vainicher C., MorelliV., Spada A., Crosti C., Chiodini I.: Vitamin D and skeletal health inautoimmune bullous skin diseases: a case control study. OrphanetJ. Rare Dis., 2015; 10: 8
  Google Scholar
• 70. Mason R.S., Sequeira V.B., Dixon K.M., Gordon-Thomson C., PobreK., Dilley A., Mizwicki M.T., Norman A.W., Feldman D., HallidayG.M., Reeve V.E.: Photoprotection by 1α,25-dihydroxyvitamin D andanalogs: further studies on mechanisms and implications for UVdamage.J. Steroid Biochem. Mol. Biol., 2010; 121: 164-168
  Google Scholar
• 71. Melo M.N., Ferre R., Castanho M.A.: Antimicrobial peptides: linkingpartition, activity and high membrane-bound concentrations.Nat. Rev. Microbiol., 2009; 7: 245-250
  Google Scholar
• 72. Monticielo O.A., Brenol J.C., Chies J.A., Longo M.G., Rucatti G.G.,Scalco R., Xavier R.M.: The role of BsmI and FokI vitamin D receptorgene polymorphisms and serum 25-hydroxyvitamin D in Brazilianpatients with systemic lupus erythematosus. Lupus, 2012; 21: 43-52
  Google Scholar
• 73. Moretti S., Fabbri P., Baroni G., Berti S., Bani D., Berti E., NassiniR., Lotti T., Massi D.: Keratinocyte dysfunction in vitiligo epidermis:cytokine microenvironment and correlation to keratinocyte apoptosis.Histol. Histopathol., 2009; 24: 849-857
  Google Scholar
• 74. Morizane S., Gallo R.L.: Antimicrobial peptides in the pathogenesisof psoriasis. J. Dermatol., 2012; 39: 225-230
  Google Scholar
• 75. Mostafa W.Z., Hegazy R.A.: Vitamin D and the skin: Focus ona complex relationship: a review. J. Adv. Res., 2015; 6: 793-804
  Google Scholar
• 76. Mostowska A., Lianeri M., Wudarski M., Olesińska M., JagodzińskiP.P.: Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphismsand the risk of systemic lupus erythematosus. Mol. Biol.Rep., 2013; 40: 803-810
  Google Scholar
• 77. Mouli V.P., Ananthakrishnan A.N.: Vitamin D and inflammatorybowel diseases. Aliment. Pharmacol. Ther., 2014; 39: 125-136
  Google Scholar
• 78. Niedźwiecka-Rystwej P., Mękal A., Deptuła W.: Peptydy przeciwdrobnoustrojowe– ważny element odporności naturalnej. AlergiaAstma Immunol., 2010; 15: 35-41
  Google Scholar
• 79. Niedźwiecka-Rystwej P., Tokarz-Deptuła B., Deptuła W.: Charakterystykasubpopulacji limfocytów T. Postępy Hig. Med. Dośw.,2013; 67: 371-379
  Google Scholar
• 80. Ohta M., Okabe T., Ozawa K., Urabe A., Takaku F.: 1α,25-Dihydroxyvitamin D3 (calcitriol) stimulates proliferation of humancirculating monocytes in vitro. FEBS Lett., 1985; 185: 9-13
  Google Scholar
• 81. Orton S.M., Wald L., Confavreux C., Vukusic S., Krohn J.P., RamagopalanS.V., Herrera B.M., Sadovnick A.D., Ebers G.C.: Associationof UV radiation with multiple sclerosis prevalence and sex ratio inFrance. Neurology, 2011; 76: 425-431
  Google Scholar
• 82. Ouyang W., Kolls J.K., Zheng Y.: The biological functions of Thelper 17 cell effector cytokines in inflammation. Immunity, 2008;28: 454-467
  Google Scholar
• 83. Penna G., Adorini L.: 1α,25-Dihydroxyvitamin D3 inhibits differentiation,maturation, activation and survival of dendritic cells leading toimpaired alloreactive T cell activation. J. Immunol., 2000; 164: 2405-2411
  Google Scholar
• 84. Piantoni S., Andreoli L., Scarsi M., Zanola A., Dall’Ara F., PizzorniC., Cutolo M., Airò P., Tincani A.: Phenotype modifications of T-cellsand their shift toward a Th2 response in patients with systemic lupuserythematosus supplemented with different monthly regimens ofvitamin D. Lupus, 2015; 24: 490-498
  Google Scholar
• 85. Płudowski P., Karczmarewicz E., Bayer M., Carter G., ChlebnaSokółD., Czech-Kowalska J., Dębski R., Decsi T., Dobrzańska A., FranekE., Głuszko P., Grant W.B., Holick M.F., Yankovskaya L., KonstantynowiczJ. i wsp.: Practical guidelines for the supplementation of vitaminD and the treatment of deficits in Central Europe – recommendedvitamin D intakes in the general population and groups at risk ofvitamin D deficiency. Endokrynol. Pol., 2013; 64: 319-327
  Google Scholar
• 86. Polińska B., Matowicka-Karna J., Kemona H.: Cytokiny w nieswoistychzapalnych chorobach jelit. Postępy Hig. Med. Dośw., 2009;63: 389-394
  Google Scholar
• 87. Ponsonby A.L., Pezic A., Ellis J., Morley R., Cameron F., CarlinJ., Dwyer T.: Variation in associations between allelic variants ofthe vitamin D receptor gene and onset of type 1 diabetes mellitusby ambient winter ultraviolet radiation levels: a meta-regressionanalysis. Am. J. Epidemiol., 2008; 168: 358-365
  Google Scholar
• 88. Provvedini D.M., Tsoukas C.D., Deftos L.J., Manolagas S.C.:1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science,1983; 221: 1181-1183
  Google Scholar
• 89. Quinn J.M., Neale S., Fujikawa Y., McGee J.O., Athanasou N.A.:Human osteoclast formation from blood monocytes, peritoneal macrophages,and bone marrow cells. Calcif. Tissue Int., 1998; 62: 527-531
  Google Scholar
• 90. Raczkiewicz A., Kisiel B., Kulig M., Tłustochowicz W.: Vitamin Dstatus and its association with quality of life, physical activity, anddisease activity in rheumatoid arthritis patients. J. Clin. Rheumatol.,2015; 21: 126-130
  Google Scholar
• 91. Ramagopalan S.V., Handel A.E., Giovannoni G., Rutherford SiegelS., Ebers G.C., Chaplin G.: Relationship of UV exposure to prevalenceof multiple sclerosis in England. Neurology, 2011; 76: 1410-1414
  Google Scholar
• 92. Ramanathan B., Davis E.G., Ross C.R., Blecha F.: Cathelicidins:microbicidal activity, mechanisms of action, and roles in innate immunity.Microbes Infect., 2002; 4: 361-372
  Google Scholar
• 93. Roberson E.D., Bowcock A.M.: Psoriasis genetics: breaking thebarrier. Trends Genet., 2010; 26: 415-423
  Google Scholar
• 94. Romagnani S.: Th1/Th2 cells. Inflamm. Bowel Dis., 1999; 5: 285-294
  Google Scholar
• 95. Romańska-Gocka K.: Farmakoterapia łuszczycy. Farm. Pol., 2009,65: 647-654
  Google Scholar
• 96. Sehrawat M., Arora T.C., Chauhan A., Kar H.K., Poonia A., JairathV.: Correlation of vitamin D levels with pigmentation in vitiligopatients treated with NBUVB therapy. ISRN Dermatol., 2014;2014: 493213
  Google Scholar
• 97. Sen D., Ranganathan P.: Vitamin D in rheumatoid arthritis: panaceaor placebo? Discov. Med., 2012; 14: 311-319
  Google Scholar
• 98. Skaaby T., Husemoen L.L., Thuesen B.H., Linneberg A.: Prospectivepopulation-based study of the association between vitamin Dstatus and incidence of autoimmune disease. Endocrine, 2015; 50:231-238
  Google Scholar
• 99. Slobodin G., Ahmad M.S., Rosner I., Peri R., Rozenbaum M., KesselA., Toubi E., Odeh M.: Regulatory T cells (CD4+CD25brightFoxP3+)expansion in systemic sclerosis correlates with disease activity andseverity. Cell. Immunol., 2010; 261: 77-80
  Google Scholar
• 100. Sloka S., Silva C., Wang J., Yong V.W.: Predominance of Th2 polarizationby vitamin D through a STAT6-dependent mechanism. J.Neuroinflammation, 2011; 8: 56-66
  Google Scholar
• 101. Souto M., Coelho A., Guo C., Mendonça L., Argolo S., Papi J.,Farias M.: Vitamin D insufficiency in Brazilian patients with SLE:prevalence, associated factors, and relationship with activity. Lupus,2011; 20: 1019-1026
  Google Scholar
• 102. Stasiołek M., Mycko M., Selmaj K.: Patogeneza stwardnieniarozsianego. Pol. Przegl. Neurol., 2005; 1: 92-98
  Google Scholar
• 103. Stassi G., De Maria R.: Autoimmune thyroid disease: new modelsof cell death in autoimmunity. Nat. Rev. Immunol., 2002; 2: 195-204
  Google Scholar
• 104. Suda T., Ueno Y., Fujii K., Shinki T.: Vitamin D and bone. J. Cell.Biochem., 2003; 88: 259-266
  Google Scholar
• 105. Tang J., Zhou R., Luger D., Zhu W., Silver P.B., Grajewski R.S., SuS.B., Chan C.C., Adorini L., Caspi R.R.: Calcitriol suppresses antiretinalautoimmunity through inhibitory effects on the Th17 effectorresponse. J. Immunol., 2009; 182: 4624-4632
  Google Scholar
• 106. Terao M., Yang L., Matsumura S., Yutani M., Murota H., KatayamaI.: A vitamin D analog inhibits Th2 cytokine- and TGFβ -inducedperiostin production in fibroblasts: a potential role for vitamin D inskin sclerosis. Dermatoendocrinol., 2015; 7: e1010983
  Google Scholar
• 107. Tetlow L.C., Smith S.J., Mawer E.B., Woolley D.E.: Vitamin Dreceptors in the rheumatoid lesion: expression by chondrocytes,macrophages, and synoviocytes. Ann. Rheum. Dis., 1999; 58: 118-121
  Google Scholar
• 108. Torkildsen O., Grytten N., Aarseth J., Myhr K.M., Kampman M.T.:Month of birth as a risk factor for multiple sclerosis: an update. ActaNeurol. Scand., 2012; 126 (Suppl. 195): 58-62
  Google Scholar
• 109. Trembleau S., Penna G., Bosi E., Mortara A., Gately M.K., AdoriniL.: Interleukin 12 administration induces T helper type 1 cells andaccelerates autoimmune diabetes in NOD mice. J. Exp. Med., 1995;181: 817-821
  Google Scholar
• 110. Ulitsky A., Ananthakrishnan A.N., Naik A., Skaros S., ZadvornovaY., Binion D.G., Issa M.: Vitamin D deficiency in patients withinflammatory bowel disease: association with disease activity andquality of life. J. Parenter. Enteral. Nutr., 2011; 35: 308-316
  Google Scholar
• 111. Vacca A., Cormier C., Mathieu A., Kahan A., Allanore Y.: VitaminD levels and potential impact in systemic sclerosis. Clin. Exp.Rheumatol., 2011; 29: 1024-1031
  Google Scholar
• 112. Van Amerongen B.M., Dijkstra C.D., Lips P., Polman C.H.: Multiplesclerosis and vitamin D: an update. Eur. J. Clin. Nutr., 2004; 58: 1095-1109
  Google Scholar
• 113. Wang L., Wang Z.T., Hu J.J., Fan R., Zhou J., Zhong J.: Polymorphismsof the vitamin D receptor gene and the risk of inflammatorybowel disease: a meta-analysis. Genet. Mol. Res., 2014; 13: 2598-2610
  Google Scholar
• 114. Wang T.T., Dabbas B., Laperriere D., Bitton A.J., Soualhine H.,Tavera-Mendoza L.E., Dionne S., Servant M.J., Bitton A., SeidmanE.G., Mader S., Behr M.A., White J.H.: Direct and indirect inductionby 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin β2 innateimmune pathway defective in Crohn disease. J. Biol. Chem.,2010; 285: 2227-2231
  Google Scholar
• 115. Wu J., Zhou M., Wan Y., Xu A.: CD8+ T cells from vitiligo perilesionalmargins induce autologous melanocyte apoptosis. Mol. Med.Rep., 2013; 7: 237-241
  Google Scholar
• 116. Yang L., Wei Y., Sun Y., Shi W., Yang J., Zhu L., Li M.: Interferon-gammainhibits melanogenesis and induces apoptosis in melanocytes:a pivotal role of CD8+ cytotoxic T lymphocytes in vitiligo.Acta Derm. Venereol., 2015; 95: 664-670
  Google Scholar
• 117. Yap K.S., Northcott M., Hoi A.B., Morand E.F., Nikpour M.: Associationof low vitamin D with high disease activity in an Australiansystemic lupus erythematosus cohort. Lupus Sci. Med., 2015;2: e000064
  Google Scholar
• 118. Zehnder D., Bland R., Williams M.C., McNinch R.W., Howie A.J.,Stewart P.M., Hewison M.: Extrarenal expression of 25-hydroxyvitaminD3-1α-hydroxylase. J. Clin. Endocrinol. Metab., 2001; 86: 888-894
  Google Scholar
• 119. Zerr P., Vollath S., Palumbo-Zerr K., Tomcik M., Huang J., DistlerA., Beyer C., Dees C., Gela K., Distler O., Schett G., Distler J.H.:Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.Ann. Rheum. Dis., 2015; 74: e20
  Google Scholar
• 120. Zhukouskaya V.V., Eller-Vainicher C., Shepelkevich A.P., DydyshkoY., Cairoli E., Chiodini I.: Bone health in type 1 diabetes: focuson evaluation and treatment in clinical practice. J. Endocrinol.Invest., 2015; 38: 941-950
  Google Scholar

Full text